Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study.

Research output: Contribution to journalArticlepeer-review

96 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study.'. Together they form a unique fingerprint.

Medicine and Dentistry